Clinical Trial Update: Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating alkaline citrate to lower the risk of nephrocalcinosis in preterm infants has completed. The study assessed whether alkaline c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrocalcinosis

Drugs mentioned

• Alkaline Citrate

Snippet

Sponsor: University of Cologne | Conditions: Nephrocalcinosis | Phase 3 | Status: COMPLETED